Clinical Trials


Below is a current listing of Mirati’s collaborative clinical trials. Click on a clinical trial to learn more.

BeiGene Sponsored Trials

Study BGB-900-103 - Phase 1b study of sitravatinib in combination for advanced solid tumors

A Phase 1b study to assess sitravatinib in combination with tisleizumab in patients with advanced solid tumors

See details for this study at

Study BGB-900-104 - Phase 1/2 study of sitravatinib monotherapy and in combination for HCC or GC/GEJC

A Phase 1/2 study to investigate sitravatinib as a monotherapy and in combination with tislelizumab in patients with unresectable locally advanced or metastatic HCC or GC/GEJC

See details for this study at

To identify clinical trials that match your diagnosis, treatment history and location, call 1-844-893-5530 or use our online Study Locator

This information is not intended to replace the informed medical advice or medical treatments of a health care professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient or whether enrollment in a clinical trial is appropriate for a patient. If you have questions regarding appropriate treatment of your medical condition, you must consult a suitably qualified healthcare professional.